Akèy › Kansè Endomèt › Alabama › Mobile
Etid klinik pou Kansè Endomèt nan Mobile, AL
4 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Mobile (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- University of South Alabama Mitchell Cancer Institute, Mobile
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Ap rekriteFaz 3
- University of South Alabama, Mitchell Cancer Institute ( Site 6033), Mobile
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Ap rekriteFaz 3
- USAH Mitchell Cancer Inst, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Mobile
Etid Kansè Endomèt nan lòt vil
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Queens, NY25 etid
- Columbus, OH25 etid
- Chicago, IL25 etid
Lòt etid nan Mobile
- Kansè Poumon ki pa ti selil13 etid
- Ensifizyans kadyak13 etid
- Kansè poumon7 etid
- Kansè nan tete7 etid
- Kansè ovè7 etid
- Obèsite7 etid
- Kansè (tout kalite)6 etid
- Melanom6 etid
- Kansè poumon selil ti6 etid
- Maladi kadyovaskilè6 etid
- Fibrilasyon atriyal5 etid
- Sipwa5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.